Armata Pharmaceuticals, Inc.ARMPNYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank93
3Y CAGR+70.6%
5Y CAGR+35.9%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+70.6%/yr
vs -6.0%/yr prior
5Y CAGR
+35.9%/yr
Recent acceleration
Acceleration
+76.6pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
4.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $36.91M | +180.0% |
| 2024 | $13.18M | -70.3% |
| 2023 | $44.45M | +497.6% |
| 2022 | $7.44M | -10.2% |
| 2021 | $8.28M | +4.0% |
| 2020 | $7.97M | -55.1% |
| 2019 | $17.74M | +85.9% |
| 2018 | $9.54M | -41.4% |
| 2017 | $16.27M | -31.2% |
| 2016 | $23.64M | - |